Showing results (2341-2350 of 2,573) with videos related to

Sort By:
Pageof 258
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2021
Crizotinib in Patients With MET-Amplified NSCLCD Ross Camidge, Gregory A Otterson, Jeffrey W Clark, et al.
Neoplasia (New York, N.Y.)|February 4, 2009
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendationsAnwar R Padhani, Guoying Liu, Dow Mu Koh, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2005
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade gliomaDaniel A Hamstra, Thomas L Chenevert, Bradford A Moffat, et al.
JAMA Network Open|July 15, 2025
Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non-Small Cell Lung Cancer: Update From the COAST Randomized Clinical TrialCharu Aggarwal, Alex Martinez-Marti, Margarita Majem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2011
A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancerFred R Hirsch, Fairooz Kabbinavar, Tim Eisen, et al.
Nature Communications|July 24, 2020
Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolutionYinghua Li, Bo Li, Wei Li, et al.
Neoplasia (New York, N.Y.)|March 16, 2011
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical researchJohn Kurhanewicz, Daniel B Vigneron, Kevin Brindle, et al.
Academic Radiology|February 23, 2019
Reprint of: Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in SmokersWassim W Labaki, Tian Gu, Susan Murray, et al.
Orphanet Journal of Rare Diseases|April 30, 2013
Intellectual disability associated with a homozygous missense mutation in THOC6Chandree L Beaulieu, Lijia Huang, A Micheil Innes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemiasJudith E Karp, Antonino Passaniti, Ivana Gojo, et al.
Pageof 258